Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3 EUR | +1.35% | 0.00% | -18.90% |
Mar. 27 | Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment | MT |
Mar. 25 | Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024 |
- Stock Market
- Equities
- HPHA Stock
- HPHA Stock
- News Heidelberg Pharma AG